首页> 外文OA文献 >Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment
【2h】

Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment

机译:将处方药监控程序(PDMP)整合到药房实践中:改善临床决策并支持药剂师的专业判断

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPharmacists have shared responsibility to investigate the validity of controlled substance prescriptions (CSPs) that raise concerns, or red flags, and subsequently exercise their right to refuse to dispense a CSP if its validity cannot be verified. Improving access to clinical practice tools, such as prescription drug monitoring programs (PDMPs), may increase availability of a patient's drug history, which is critical to making informed clinical decisions about dispensing CSPs.ObjectivesThe purpose of this study was to examine how integration and consistent use of a PDMP in pharmacy practice impacts pharmacists' dispensing practices related to CSPs.MethodsA cross-sectional study examined pharmacists' knowledge and use of Indiana's (US State) PDMP (INSPECT) and dispensing practices of CSPs. Three outcome measures were analyzed using multiple logistic regression so as to examine the relationship between PDMP use and pharmacists' controlled substance dispensing behaviors.ResultsPharmacists were 6.4 times more likely to change their dispensing practice to dispense fewer CSPs if they reported that INSPECT provides increased access to patient information. Pharmacists who always use INSPECT refused an average of 25 CSPs annually compared to an average of 7 refusals for pharmacists not using INSPECT. Pharmacists using INSEPCT consistently (at every visit) were 3.3 times more likely to refuse to dispense more CSPs than pharmacists who report never using INSPECT.ConclusionsIntegration of PDMPs in pharmacy practice may improve a pharmacist's ability to make informed clinical decisions and exercise sound professional judgment. Providing clinical practice tools to both prescribers and pharmacists is important to preventing drug diversion and prescription drug abuse. Future research should focus on understanding the barriers and challenges to successful integration of PDMPs in pharmacy practice.
机译:背景技术药剂师有责任调查引起关注或危险信号的受控物质处方(CSP)的有效性,如果无法验证其有效性,则随后行使其拒绝分发CSP的权利。改善对临床实践工具(例如处方药监测程序(PDMP))的访问可能会增加患者药物史的可用性,这对于做出有关分配CSP的明智临床决定至关重要。目的本研究的目的是检查整合和一致性如何方法一项横断面研究检查了药剂师对印第安纳州(美国)PDMP(INSPECT)的了解和使用以及CSP的分配实践。使用多元Logistic回归分析了三种结果指标,以检验PDMP使用与药剂师控制药物分配行为之间的关系。结果如果药剂师报告INSPECT提供了更多的获得CSP的机会,则他们改变其分配实践以分配更少的CSP的可能性高6.4倍患者信息。始终使用INSPECT的药剂师每年平均拒绝25个CSP,而不使用INSPECT的药剂师平均拒绝7次。与报告从未使用过INSPECT的药剂师相比,始终使用INSEPCT的药剂师(每次探访)拒绝分配更多CSP的可能性是未曾使用INSPECT的药剂师的3.3倍。结论将PDMP整合到药剂学实践中可能会提高药剂师做出明智的临床决策和行使专业判断的能力。向处方者和药剂师提供临床实践工具对于防止药物转移和处方药物滥用很重要。未来的研究应侧重于理解PDMP在药房实践中成功整合的障碍和挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号